|
On Friday, March 5, 2010, over thirty Canadian health stakeholders (representing patients, providers, government, academics and industry) participated in a roundtable meeting to discuss the new paradigm of benefit-risk introduced in Bill C-51.
|
|
Read more
|
|
|
Written by Elisabeth Fowler
|
|
Elisabeth Fowler delivered the attached presentation at the Drug Information Association conference in Ottawa, Canada in November, 2009.
|
|
Read more
|
|
The joint WHO/UNICEF/World Bank briefing served primarily to launch their State of the World’s Vaccines and Immunization Report.
While the report contained encouraging results, these organizations stressed the need to continued vigilance and called on donor nations to address the funding gap that still leaves millions of children at risk.
|
|
Read more
|
|
Written by Elisabeth Fowler
|
|
World Health Advocacy co-hosted the "Access to Rx Drugs: What Every Patient Should Know" workshop held in Toronto, ON on September 21 & 22, 2009. Elisabeth Fowler helped to moderate the workshop and also delivered the attached presentation, providing an overview of public engagement in HTA evaluations in other countries.
|
|
Read more
|
|
Written by Elisabeth Fowler
|
|
World Health Advocacy co-hosted the "Access to Rx Drugs: What Every Patient Should Know" workshop held in Toronto, ON on September 21 & 22, 2009. Elisabeth Fowler helped to moderate the workshop and also delivered the attached presentation, providing an overview of the process of medical innovation.
|
|
Read more
|
|
|
|
|
<< Start < Prev 1 2 3 Next > End >>
|
|
Page 1 of 3 |
